• Explore /
  • Poster
  • / Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki-67.

Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki-67.

Abstract Poster

Authors

null

Fengnian Zhao

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China

Fengnian Zhao , Jinge Zhao , Yifu Shi , Xinyuan Wei , Ni Chen , Pengfei Shen , Hao Zeng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 176)

DOI

10.1200/JCO.2024.42.4_suppl.176

Abstract #

176

Poster Bd #

H5

Abstract Disclosures

Similar Posters

First Author: Yifu Shi

First Author: Jian Guan

Poster

2024 ASCO Genitourinary Cancers Symposium

Quality of treatment with targeted agents for advanced prostate cancer by treating specialist.

Quality of treatment with targeted agents for advanced prostate cancer by treating specialist.

First Author: Kassem S Faraj

First Author: Pasquale Rescigno